140 related articles for article (PubMed ID: 12110280)
1. Synthesis of a new platinum(II) complex: anticancer activity and nephrotoxicity in vitro.
Marzano C; Trevisan A; Giovagnini L; Fregona D
Toxicol In Vitro; 2002 Aug; 16(4):413-9. PubMed ID: 12110280
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity and DNA damage induced by a new platinum(II) complex with pyridine and dithiocarbamate.
Marzano C; Fregona D; Baccichetti F; Trevisan A; Giovagnini L; Bordin F
Chem Biol Interact; 2002 Aug; 140(3):215-29. PubMed ID: 12204578
[TBL] [Abstract][Full Text] [Related]
4. Mixed complexes of Pt(II) and Pd(II) with ethylsarcosinedithiocarbamate and 2-/3-picoline as antitumor agents.
Giovagnini L; Marzano C; Bettio F; Fregona D
J Inorg Biochem; 2005 Nov; 99(11):2139-50. PubMed ID: 16165215
[TBL] [Abstract][Full Text] [Related]
5. Platinum(II) and palladium(II) complexes with dithiocarbamates and amines: synthesis, characterization and cell assay.
Faraglia G; Fregona D; Sitran S; Giovagnini L; Marzano C; Baccichetti F; Casellato U; Graziani R
J Inorg Biochem; 2001 Jan; 83(1):31-40. PubMed ID: 11192697
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of a palladium(II)-dithiocarbamate complex: biological assay and nephrotoxicity in rats.
Trevisan A; Marzano C; Cristofori P; Borella Venturini M; Giovagnini L; Fregona D
Arch Toxicol; 2002 Jun; 76(5-6):262-8. PubMed ID: 12107643
[TBL] [Abstract][Full Text] [Related]
7. Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands.
Marqués-Gallego P; Kalayda GV; Jaehde U; Dulk Hd; Brouwer J; Reedijk J
J Inorg Biochem; 2009 May; 103(5):791-6. PubMed ID: 19303143
[TBL] [Abstract][Full Text] [Related]
8. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.
Ronconi L; Giovagnini L; Marzano C; Bettìo F; Graziani R; Pilloni G; Fregona D
Inorg Chem; 2005 Mar; 44(6):1867-81. PubMed ID: 15762713
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
10. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
[TBL] [Abstract][Full Text] [Related]
11. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
[TBL] [Abstract][Full Text] [Related]
12. Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance.
Kelland LR; Sharp SY; O'Neill CF; Raynaud FI; Beale PJ; Judson IR
J Inorg Biochem; 1999 Oct; 77(1-2):111-5. PubMed ID: 10626362
[TBL] [Abstract][Full Text] [Related]
13. Platinum(IV)-nitroxyl complexes as possible candidates to circumvent cisplatin resistance in RT112 bladder cancer cells.
Cetraz M; Sen V; Schoch S; Streule K; Golubev V; Hartwig A; Köberle B
Arch Toxicol; 2017 Feb; 91(2):785-797. PubMed ID: 27307157
[TBL] [Abstract][Full Text] [Related]
14. Platinum anticancer drugs. From serendipity to rational design.
Monneret C
Ann Pharm Fr; 2011 Nov; 69(6):286-95. PubMed ID: 22115131
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo antitumor activity of platinum(II) complexes with thiosemicarbazones derived from 2-formyl and 2-acetyl pyridine and containing ring incorporated at N(4)-position: synthesis, spectroscopic study and crystal structure of platinum(II) complexes with thiosemicarbazones, potential anticancer agents.
Kovala-Demertzi D; Papageorgiou A; Papathanasis L; Alexandratos A; Dalezis P; Miller JR; Demertzis MA
Eur J Med Chem; 2009 Mar; 44(3):1296-302. PubMed ID: 18848372
[TBL] [Abstract][Full Text] [Related]
16. Characterization studies and cytotoxicity assays of Pt(II) and Pd(II) dithiocarbamate complexes by means of FT-IR, NMR spectroscopy and mass spectrometry.
Alverdi V; Giovagnini L; Marzano C; Seraglia R; Bettio F; Sitran S; Graziani R; Fregona D
J Inorg Biochem; 2004 Jun; 98(6):1117-28. PubMed ID: 15149823
[TBL] [Abstract][Full Text] [Related]
17. Pt(II) and Pd(II) derivatives of ter-butylsarcosinedithiocarbamate. Synthesis, chemical and biological characterization and in vitro nephrotoxicity.
Fregona D; Giovagnini L; Ronconi L; Marzano C; Trevisan A; Sitran S; Biondi B; Bordin F
J Inorg Biochem; 2003 Jan; 93(3-4):181-9. PubMed ID: 12576280
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, antitumor activity, and chemical properties of silaplatin and related platinum (II) and platinum (IV) complexes derived from beta-silyl amines.
Anderson WK; Kasliwal R; Houston DM; Wang YS; Narayanan VL; Haugwitz RD; Plowman J
J Med Chem; 1995 Sep; 38(19):3789-97. PubMed ID: 7562909
[TBL] [Abstract][Full Text] [Related]
19. In vitro cytotoxicity study on platinum (II) complexes with epoxysuccinates as leaving groups.
Liu X; Shen H; Zhu H; Cui K; Gou S
Bioorg Med Chem Lett; 2007 Jul; 17(14):3831-4. PubMed ID: 17533124
[TBL] [Abstract][Full Text] [Related]
20. Enhanced anticancer potency with reduced nephrotoxicity of newly synthesized platin-based complexes compared with cisplatin.
Salehi R; Abyar S; Ramazani F; Khandar AA; Hosseini-Yazdi SA; White JM; Edalati M; Kahroba H; Talebi M
Sci Rep; 2022 May; 12(1):8316. PubMed ID: 35585092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
